1-methyl-3-isobutylxanthine has been researched along with Cardiovascular Stroke in 4 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avendano, CE | 1 |
Billman, GE | 1 |
Gaballa, MA | 1 |
Eckhart, A | 1 |
Koch, WJ | 1 |
Goldman, S | 1 |
Boixel, C | 1 |
Gonzalez, W | 1 |
Louedec, L | 1 |
Hatem, SN | 1 |
Pagani, ED | 1 |
Buchholz, RA | 1 |
Silver, PJ | 1 |
4 other studies available for 1-methyl-3-isobutylxanthine and Cardiovascular Stroke
Article | Year |
---|---|
Effect of interventions that increase cyclic AMP levels on susceptibility to ventricular fibrillation in unanesthetized dogs.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Anesthesia; | 1994 |
Vascular beta-adrenergic receptor system is dysfunctional after myocardial infarction.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Animals; Aorta; Aurora Kinases; Blood Pressur | 2001 |
Mechanisms of L-type Ca(2+) current downregulation in rat atrial myocytes during heart failure.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Animals; Atrial Natriuretic Factor; Calcium; | 2001 |
Cardiovascular cyclic nucleotide phosphodiesterases and their role in regulating cardiovascular function.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Atrial Natriuretic Factor; Cyclic GMP; Heart Failure; Humans; | 1992 |